Quickly review your physical exam skills, and make evidence informed clinical decisions. All while earning CME Credit.

  • CME Credits icon

What is the evidence for tenoxicam injections in the treatment of subacromial impingement syndrome?

Summary

Patient Population:

Single study identified: n=80. All patients had rotator cuff tendonitis.

Intervention:

Tenoxicam (20mg/2mL) once a week for up to 4 weeks.

Comparison:

It appears that they included 3 reviews and an additional 5 RCTs that did not appear in any of those 3 reviews. From within the identified reviews, they included information from 11, 9 and 7 trials. Tables are provided reporting the information abstracted from each trial in the categories corresponding to where they were found.

Outcome:

  1. Pain: One low-quality RCT demonstrated significant improvement in terms of pain at rest and during active movement in favour of injection vs. placebo.  Significant improvements associated with injection (vs. placebo) were also reported in terms of shoulder mobility.

Outcomes Assessed

  • Benefit
  • Harm
  • Inconclusive

Tenoxicam Injection vs. Placebo

Pain

ROM

CME Information / Site Feedback

Your Name (required)

Your Email (required)

1. What is the impact of this information on you or your practice?

Note: Check all that apply. You may check more than one box.

 I learned something new I am motivated to learn more This information confirmed I did (am doing) the right thing I am reassured I am reminded of something I already knew I am dissatisfied There is a problem with the presentation of this information I disagree with the content of this information This information is potentially harmful

2. Is this information relevant for at least one of your patients?

 Totally relevant Partially relevant Not relevant

3. Will you use this information for a specific patient?

 Yes No Possibly I already know about this information, and I'm Already Using it.

4. Please rate the websites ease of use.

1 2 3 4 5 

5. Likelihood of using site again/recommending the site.

1 2 3 4 5 

Additional Information

×

Example AMSTAR Information

example amstar rating guidlines example amstar rating guidlines ×